InnoPran XL (propranolol hydrochloride) NDC 62559-591

NDC codes

FDA NDC Directory

Product NDC (as listed)62559-591Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62559-0591Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62559-591-14	62559059114	14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-591-14)Marketed from Sep 1, 2021 · Sample package
62559-591-30	62559059130	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-591-30)Marketed from Feb 22, 2018
62559-591-77	62559059177	7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-591-77)Marketed from Feb 22, 2018 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): InnoPran XL
Generic name (nonproprietary): propranolol hydrochloride
Active ingredients: Propranolol hydrochloride — 120 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021438
Marketing start: Feb 22, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 62559-591_6fe5d83e-6354-4d56-aa20-ff364432a6adSPL ID 6fe5d83e-6354-4d56-aa20-ff364432a6adSPL set ID cd5601b3-4d87-4c3b-acac-b476e787609dRxCUI 856460, 856471, 856569, 856576UNII F8A3652H1VUPC 0362559591300, 0362559590303
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462559059114 followed by a unit qualifier and the quantity

Package 62559-0591-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 27, 2026.

Indications (excerpt from the label)

INNOPRAN XL is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including beta-blockers. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advic…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021438

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021438
Product	Strength	Form · route	Labeler	Product NDC
InnoPran XLpropranolol hydrochloride	Propranolol hydrochloride 80 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-590
Inderal XLpropranolol hydrochloride	Propranolol hydrochloride 80 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-600
Inderal XLpropranolol hydrochloride	Propranolol hydrochloride 120 mg/1	Capsule, Extended releaseOral	ANI Pharmaceuticals, Inc.	62559-601